<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7097833/results/search/country/results.xml">
  <result pre="font-style : italic;} Infect Dis RepIDRInfectious Disease Reports2036-74302036-7449PAGEPress Publications, Pavia," exact="Italy" post="pmcid: 7097833 pmid: 32218915 doi: 10.4081/idr.2020.8543 : Expert Opinion"/>
  <result pre="Group (ICOTREG)*[], National Institute for Infectious Diseases &quot;L. Spallanzani&quot;IRCCS, Rome," exact="Italy" post="National Institute for Infectious Diseases &quot;L. Spallanzani&quot;, IRCCS, Via"/>
  <result pre="On March 9 2020, WHO declared COVID-19 a global pandemic." exact="Italy" post="is the second most affected country by COVID-19 infection"/>
  <result pre="spreading outbreak of human respiratory disease (COVID-2019), both within People’s" exact="Republic of" post="China and in several other countries worldwide. On March"/>
  <result pre="of human respiratory disease (COVID-2019), both within People’s Republic of" exact="China" post="and in several other countries worldwide. On March 9"/>
  <result pre="March 9 2020, WHO declared COVID-19 a global pandemic. Currently," exact="Italy" post="is the second most affected country by COVID-19 infection"/>
  <result pre="after China. The first autochthonous infection case was confirmed in" exact="Italy" post="on February 21 2020 and up to now (March"/>
  <result pre="remdesivir in inhibiting replication of SARS-COV2. Moreover, emerging reports from" exact="China" post="suggests that chloroquine has shown a superiority in reducing"/>
  <result pre="In light of this results, an expert consensus group in" exact="China" post="has recommended chloroquine for COVID-19 treatment. Dosage The recommended"/>
  <result pre="for compassionate use, in the first patients with COVID-19 in" exact="the United States." post="Two ongoing clinical randomized clinical trials in China are"/>
  <result pre="compassionate use, in the first patients with COVID-19 in the" exact="United States." post="Two ongoing clinical randomized clinical trials in China are"/>
  <result pre="the United States. Two ongoing clinical randomized clinical trials in" exact="China" post="are evaluating remdesivir for moderate and sever COVID-19 infections."/>
  <result pre="the lack of data on SARSCoV- 2 pathogenesis, studies in" exact="China" post="showed a possible correlation of massive inflammation and severe"/>
  <result pre="trials on TCZ efficacy and safety for COVID-19 treatment, in" exact="China" post="TCZ was recently approved for patients affected by severe"/>
  <result pre="pulmonary complications by the National Health Commission of the People’s" exact="Republic of" post="China. Preliminary data from an observational study conducted in"/>
  <result pre="of China. Preliminary data from an observational study conducted in" exact="China" post="on 21 severe cases receiving TCZ, showed an improvement"/>
  <result pre="doi: 10.1038/s41422-020-0282-0. HolshueMLDeBoltCLindquistSet al.First Case of 2019 Novel Coronavirus in" exact="the United States." post="N Engl J Med2020 Jan 31. doi: 10.1056/NEJMoa2001191. SheahanTPSimsACLeistSRet"/>
  <result pre="10.1038/s41422-020-0282-0. HolshueMLDeBoltCLindquistSet al.First Case of 2019 Novel Coronavirus in the" exact="United States." post="N Engl J Med2020 Jan 31. doi: 10.1056/NEJMoa2001191. SheahanTPSimsACLeistSRet"/>
  <result pre="respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study." exact="Hong Kong" post="Med J2003;9:399-406.14660806 ChanJFYaoYYeungMLet al.Treatment With Lopinavir/Ritonavir or Interferon- β1b"/>
  <result pre="exoribonuclease. mBio2018;9:e00221-18.29511076 HolshueMLDeBoltCLindquistSet al.First Case of 2019 Novel Coronavirus in" exact="the United States." post="N Engl J Med2020;382:929-36.32004427 collab: European Medicine Agency. Available"/>
  <result pre="mBio2018;9:e00221-18.29511076 HolshueMLDeBoltCLindquistSet al.First Case of 2019 Novel Coronavirus in the" exact="United States." post="N Engl J Med2020;382:929-36.32004427 collab: European Medicine Agency. Available"/>
 </snippets>
</snippetsTree>
